OncoCyte Reports Successful Completion of Follow on Breast Cancer Diagnostic Study
15 juin 2017 07h00 HE
|
OncoCyte Corporation
ALAMEDA, Calif., June 15, 2017 (GLOBE NEWSWIRE) -- OncoCyte Corporation (NYSE MKT:OCX), a developer of novel, non-invasive tests for the early detection of cancer, announced today that it has...
OncoCyte Corporation Set to Join Russell 3000® Index
12 juin 2017 07h00 HE
|
OncoCyte Corporation
ALAMEDA, Calif., June 12, 2017 (GLOBE NEWSWIRE) -- OncoCyte Corporation (NYSE MKT:OCX), a developer of novel, non-invasive blood-based liquid biopsy tests for the early detection of cancer,...
OncoCyte Presents Positive Lung Cancer Blood Test Data at American Thoracic Society
22 mai 2017 14h45 HE
|
OncoCyte Corporation
- Continues Plans to Commercialize Lung Cancer Diagnostic Test in 2017 - - Conference Call Today at 4:30 PM Eastern Daylight Time - ALAMEDA, Calif., May 22, 2017 (GLOBE NEWSWIRE) -- OncoCyte...
OncoCyte Executive to Address Next Generation Dx Summit on Successful Reimbursement Strategies for Diagnostic Tests
09 mai 2017 07h00 HE
|
OncoCyte Corporation
ALAMEDA, Calif., May 09, 2017 (GLOBE NEWSWIRE) -- OncoCyte Corporation (NYSE MKT:OCX), a developer of novel, non-invasive tests for the early detection of cancer, announced today that William...
OncoCyte Establishes Medical Advisory Committee to Enhance Development Strategy for Lung Cancer Diagnostics
04 mai 2017 07h00 HE
|
OncoCyte Corporation
ALAMEDA, Calif., May 04, 2017 (GLOBE NEWSWIRE) -- OncoCyte Corporation (NYSE MKT:OCX), a developer of novel, non-invasive blood-based tests to aid in the early detection of cancer, today announced...
OncoCyte Continues to Make Progress Towards Commercialization; Reports First Quarter 2017 Results
28 avr. 2017 07h00 HE
|
OncoCyte Corporation
Expects to Report Results of 300 Patient R&D Validation Study on May 22, 2017 Conference Call Scheduled for May 22, 2017 at 4:30pm ET ALAMEDA, Calif., April 28, 2017 (GLOBE NEWSWIRE) --...
OncoCyte Submits Application for CLIA Certification of its Laboratory
21 mars 2017 07h00 HE
|
OncoCyte Corporation
ALAMEDA, Calif., March 21, 2017 (GLOBE NEWSWIRE) -- OncoCyte Corporation (NYSE MKT:OCX), a developer of novel, non-invasive blood based tests to aid in the early detection of cancer, has submitted...
OncoCyte Reports Successful Results of Lung Cancer Diagnostic Test Study; Targets 2017 Product Launch to Address $4 Billion-plus Market
06 mars 2017 07h00 HE
|
OncoCyte Corporation
Data from the Study Exceed Levels Believed Necessary for a Commercially Successful Test Conference Call Scheduled for Today at 4:30 PM ET ALAMEDA, Calif., March 06, 2017 (GLOBE NEWSWIRE) --...
OncoCyte Corporation to Present at Cowen and Company 37th Annual Health Care Conference
01 mars 2017 07h30 HE
|
OncoCyte Corporation
ALAMEDA, Calif., March 01, 2017 (GLOBE NEWSWIRE) -- OncoCyte Corporation (NYSE MKT:OCX), a developer of novel, non-invasive blood based tests for the early detection of cancer, announced today that...
OncoCyte Corporation Reports Fourth Quarter and Full Year 2016 Financial Results
27 févr. 2017 16h10 HE
|
OncoCyte Corporation
Enters into New Credit Facility with Silicon Valley Bank Conference Call Scheduled for Monday, March 6, 2017 at 4:30 PM ET ALAMEDA, Calif., Feb. 27, 2017 (GLOBE NEWSWIRE) -- OncoCyte Corporation...